Date: 30 Oct 2007
Critically Ill Cancer Patients are not Consistently Hypercoagulable after Craniotomy
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Recent reports using thrombelastography have suggested that neurosurgical patients develop a hypercoagulable state in the postoperative period. Since venous thromboembolism is a potentially life threatening complication in these patients, we studied a similar population in our institution.
We conducted a prospective pilot study to evaluate postoperative coagulation changes in critically ill cancer patients after craniotomy. Data collected included demographics, diagnoses, severity of illness, all hematological information (coagulation tests included conventional and TEG), therapies, and complications. Analysis included descriptive statistics, and multivariate regression analysis.
Eleven patients were included in the study. Mean age was 52 ± 17 years, BMI 28 ± 6.5, APACHE II and SOFA scores were 11.18 ± 5.0 and 3.82 ± 1.6 respectively. The Coagulation Index (CI), which is derived from the measured values of R, K, MA, and alpha angle was 1.22 ± 3.5, R 4.2 ± 1.6, K 2.0 ± 2.1, MA 60.78 ± 5.97, and alpha angle 66.88 ± 14.9; while the Thrombodynamic Potential Index (TPI), which is derived from the measured values of K and MA only was 32.48 ± 21. The CI correlated significantly with R, K, alpha angle, MA, TMA, TPI, PMA, E, A30 and A60 but not with the PTT, INR, or SOFA and APACHE II scores. One patient was hypocoagulable by CI and TPI values; in contrast, nine patients were hypercoagulable by TPI but only one by CI. There were no cases of VTE.
Hypercoagulability as defined by the CI was not a common finding in this study. Although the TPI indicated hypercoagulability in a large number of patients, we do not believe it is a good tool to assess the patient’s clotting status or predictor of thrombosis because in contrast to the CI, it does not take into account the enzymatic portions of the clotting cascade. A larger TEG study is warranted to determine the clinical significance of these changes in this and other populations.
Sawaya R, Ramo OJ, Glas-Greenwalt P, Wu SZ. Plasma fibrinolytic profile in patients with brain tumors. Thromb Haemost 1991;65(1):15–9.PubMed
Sawaya R, Zuccarello M, Elkalliny M, Nishiyama H. Postoperative venous thromboembolism and brain tumors: Part I. Clinical profile. J Neurooncol 1992;142(2):119–25.
Sawaya R, Glas-Greenwalt P. Postoperative venous thromboembolism and brain tumors: Part II. Hemostatic profile. J Neurooncol 1992;14(2):127–34.PubMed
Sawaya R, Highsmith RF. Postoperative venous thromboembolism and brain tumors: Part III. Biochemical profile. J Neurooncol 1992;14(2):113–8.PubMed
Goh KY, Tsoi WC, Feng CS, Wickham N, Poon WS. Haemostatic changes during surgery for primary brain tumors. J Neurol Neurosurg & Psych 1997;63:334–38.
Whitten C, Greilich PE. Thromboelastography® past, present, and future. Anesthesiol 2000;92(5): 1223–25.CrossRef
Traverso CI, Caprini JA, Arcelus JI. The normal thrombelastogram and its interpretation. Semin Thromb Hemost 1995;21(4): 7–13.PubMed
Kim HW, Stubdal H, Greenburg AG. Coagulation dynamics after hemodilution with polyhemoglobin. Surg Gynecol Obstet 1992;175:219–26.PubMed
Ng KF, Lo JW. The development of hypercoagulability state, as measured by thrombelastography, associated with intraoperative surgical blood loss. Anaesth Intens Care 1996;24(1):20–5.
Gibbs NM. The effect of anesthetic agents on platelet function. Anesth Intens Care 1991;19(4):495–520.
Bjoraker DG. The thrombelastograph D coagulation Analyzer. Anesthesiol Review 1991;XVIII(4):34–8.
Kaufmann CR, Dwyer KM, Crews JD, Dols SJ, Trask AL. Usefulness of Thrombelastography in assessment of trauma patient coagulation. J Trauma 1997;42(4):716–22.PubMed
Flinn WR, Sandager G, Silva MB, Benjamin ME, Cerullo LJ, Taylor M. Prospective surveillance for perioperative venous thrombosis: experience in 2643 patients. Arch Surg 1996;131:472–80.PubMed
Bodin D, Martin L, Dubos J, Couvret C, Santini JJ, Mercier C. Consumption coagulopathy and meningioma. Ann Fr Anesth Reanim 1986;5(3):308–11.PubMed
Huang PS, Koo KE. Diffuse intravascular coagulation associated with brain tumor surgery in children. Pediatr Neurosurg 1990–1991;16(1):43–7.CrossRef
Dragoni F, Mazzucconi MG, Acqui M, Ferrante L, Rosa G, Mastronardi L, Chistolini A, deSanctis V, Mandelli F. Coagulation study in patients who had undergone surgery for meningioma. Haemostasis 1993;23(6):301–7.PubMed
Thomas D. Venous thrombogenesis. Br Med Bull 1994;50(4):803–12.PubMed
Bauer K, Rosendaal FR, Heit JA. Hypercoagulability: too many tests, too much conflicting data. Hematology 2002;2002:353–68.CrossRef
- Critically Ill Cancer Patients are not Consistently Hypercoagulable after Craniotomy
Volume 7, Issue 3 , pp 211-216
- Cover Date
- Print ISSN
- Online ISSN
- Humana Press Inc
- Additional Links
- Disseminated intravascular coagulation
- Industry Sectors
- Author Affiliations
- 1. Department of Critical Care Medicine, Division of Anesthesiology and Critical Care, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Unit 112, Houston, TX, 77030, USA
- 2. Laboratory Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
- 3. Department of Anesthesiology, Duke University Medical Center, Durham, NC, USA